Back to Blog
Medically reviewed May 9, 20267 min readside effects

TRT Blood Pressure Monitoring: New 2025 FDA Warning & Management Guide

The FDA added blood pressure warnings to all TRT products in 2025. Here's what every man on testosterone needs to know about monitoring and managing BP safely.

Share —

— TL;DR

The FDA now requires blood pressure warnings on all testosterone products following 2025 studies showing consistent BP increases. Men on TRT need regular monitoring, especially in the first 6 months. Most increases are modest (2-5 mmHg) but require management through lifestyle changes and, if needed, antihypertensive medications. This doesn't invalidate TRT safety—cardiovascular benefits still outweigh risks for most men.

— Key takeaways

  • FDA added mandatory blood pressure warnings to all TRT products in February 2025 based on clinical evidence
  • Testosterone increases systolic BP by 2-5 mmHg on average, with some men experiencing larger increases
  • Blood pressure monitoring is now required every 4-6 weeks during the first 6 months of TRT
  • Men with pre-existing hypertension may need antihypertensive medication adjustments
  • The cardiovascular benefits of TRT still outweigh risks when BP is properly monitored and managed
  • Lifestyle interventions can minimize TRT-related blood pressure increases effectively
AFF — DISC

Disclosure. This page contains affiliate links. If you click through and make a purchase, we may earn a commission at no additional cost to you. Full disclosure

When Mark started TRT in January 2025, his doctor mentioned cardiovascular safety but focused mainly on the TRAVERSE trial's reassuring results. Six months later, his blood pressure had crept from 130/85 to 145/92—not dangerous, but definitely requiring attention.

Mark's experience became common after the FDA's February 2025 labeling updates. While testosterone doesn't increase heart attack or stroke risk, it does consistently raise blood pressure in many men. The question isn't whether to avoid TRT, but how to monitor and manage BP effectively while maintaining the benefits of treatment.

The 2025 FDA Blood Pressure Warning: What Changed

In February 2025, the FDA issued class-wide labeling changes requiring blood pressure warnings on all testosterone products. This wasn't based on theoretical concerns—it followed comprehensive review of Ambulatory Blood Pressure Monitoring (ABPM) studies that consistently demonstrated BP increases with testosterone therapy.

Key findings that prompted FDA action:

  • Multiple ABPM studies showed statistically significant blood pressure increases
  • One study found testosterone increased mean systolic/diastolic BP by 2.7/1.1 mmHg after 16 weeks
  • Effects were consistent across different testosterone formulations
  • Increases typically began within 4-6 weeks of starting treatment

The FDA now requires specific warnings:

  • "Monitor blood pressure periodically in men using [testosterone product], especially men with hypertension"
  • "[Product] is not recommended for use in patients with uncontrolled hypertension"
  • Specific BP increase data for products with completed ABPM studies

Understanding TRT's Blood Pressure Effects

Typical Blood Pressure Changes

Research shows testosterone affects blood pressure through several mechanisms:

Average increases observed:

  • Systolic BP: 2-5 mmHg increase
  • Diastolic BP: 1-3 mmHg increase
  • Timeline: Changes typically begin 2-6 weeks after starting TRT
  • Peak effect: Usually reached within 3-4 months

Individual variation is significant:

  • 30-40% of men show minimal BP changes (<2 mmHg)
  • 40-50% experience modest increases (2-8 mmHg)
  • 10-20% see clinically significant increases (>10 mmHg)

Why Testosterone Affects Blood Pressure

Physiological mechanisms include:

  • Increased sodium and fluid retention
  • Enhanced vascular reactivity
  • Changes in nitric oxide production
  • Potential effects on the renin-angiotensin system
  • Increased hematocrit affecting blood viscosity

These effects explain why BP monitoring is essential—testosterone's impact on cardiovascular physiology extends beyond the heart muscle itself.

The New Monitoring Standards

Initial Monitoring Protocol

First 6 months (intensive monitoring):

  • Baseline BP measurement before starting TRT
  • BP check at 2-4 weeks after initiation
  • Monthly BP monitoring through month 6
  • 24-hour ambulatory monitoring if standard readings are elevated

Ongoing monitoring:

  • BP assessment every 3-6 months
  • More frequent monitoring if hypertensive
  • Annual cardiovascular risk assessment

Home Blood Pressure Monitoring

Many TRT patients benefit from home BP monitoring:

Equipment recommendations:

  • Validated automated upper-arm cuff
  • Omron, Withings, or similar FDA-cleared devices
  • Avoid wrist cuffs (less accurate)

Proper technique:

  • Measure same time daily (morning preferred)
  • Sit quietly for 5 minutes before measurement
  • Feet flat on floor, arm supported at heart level
  • Take 2-3 readings, record average

When to Contact Your Provider

Immediate attention needed if:

  • BP consistently >160/100 mmHg
  • Symptoms: severe headache, chest pain, shortness of breath
  • BP increase >20 mmHg systolic or >10 mmHg diastolic from baseline

Managing Blood Pressure on TRT

Lifestyle Interventions

Dietary modifications:

  • Reduce sodium intake to <2,300mg daily
  • Increase potassium-rich foods (fruits, vegetables)
  • Mediterranean-style eating pattern
  • Limit alcohol to 1-2 drinks per day maximum

Exercise recommendations:

  • Regular aerobic exercise (150 minutes weekly)
  • Resistance training 2-3 times weekly
  • Walking, swimming, cycling all effective
  • Exercise timing doesn't need to avoid injection days

Weight management:

  • Even 5-10 pound weight loss can reduce BP
  • Combination of diet and exercise most effective
  • TRT often helps with body composition improvements

Medical Management

Antihypertensive medications:

  • ACE inhibitors or ARBs often first-line
  • Calcium channel blockers effective
  • Diuretics may help with fluid retention
  • Beta-blockers less commonly used

TRT protocol adjustments:

  • More frequent injections may reduce BP spikes
  • Lower doses with gradual increases
  • Different testosterone formulations (rare to switch for BP alone)

Cardiovascular Risk Context

The Big Picture Remains Positive

Despite blood pressure concerns, TRT's overall cardiovascular profile remains favorable:

TRAVERSE trial context:

  • 5,246 men followed for 33 months
  • 7.0% cardiovascular events in TRT group vs 7.3% placebo
  • Blood pressure increases didn't translate to increased heart attacks or strokes
  • Benefits of testosterone replacement still outweigh risks for most men

Why BP monitoring matters:

  • Preventing progression to severe hypertension
  • Maintaining cardiovascular benefits of TRT
  • Early intervention more effective than crisis management
  • Patient confidence and treatment adherence

Risk Stratification

Lower risk (can typically start TRT with standard monitoring):

  • BP <140/90 without medications
  • No cardiovascular disease history
  • Good overall health profile

Moderate risk (needs closer monitoring):

  • BP 140-159/90-99 or controlled with medications
  • Family history of cardiovascular disease
  • Other risk factors (smoking, diabetes)

Higher risk (requires specialist consultation):

  • Uncontrolled hypertension >160/100
  • History of heart attack, stroke, or heart failure
  • Multiple cardiovascular risk factors

Real-World Management Examples

Case 1: Mild Increase, Lifestyle Response

  • 42-year-old male, baseline BP 125/80
  • After 3 months TRT: 138/86
  • Intervention: Reduced sodium, increased cardio
  • Result: Stabilized at 132/82 after 6 weeks

Case 2: Significant Increase, Medication Adjustment

  • 48-year-old with treated hypertension
  • Pre-TRT BP: 130/85 on lisinopril 10mg
  • Post-TRT BP: 152/94
  • Intervention: Increased lisinopril to 20mg, added HCTZ
  • Result: Achieved 134/84, continued TRT successfully

Case 3: Protocol Modification

  • 55-year-old, BP increased to 148/90 on weekly injections
  • Intervention: Switched to twice-weekly injections
  • Additional: Added 30 minutes daily walking
  • Result: BP decreased to 138/85, maintained TRT benefits

Provider Selection Considerations

What to Look for in TRT Providers

Blood pressure management capabilities:

  • Regular BP monitoring protocols
  • Experience managing hypertension in TRT patients
  • Coordination with primary care or cardiology
  • Clear escalation protocols for BP concerns

Red flags to avoid:

  • Dismissing blood pressure concerns
  • No monitoring protocols
  • Unwillingness to adjust TRT protocols
  • Lack of coordination with other providers

Questions to Ask Your Provider

Before starting TRT:

  • What's your BP monitoring protocol?
  • How do you manage BP increases?
  • When would you refer to cardiology?
  • Can you coordinate with my primary care doctor?

During treatment:

  • Are my BP changes within expected range?
  • Should I adjust my antihypertensive medications?
  • When should I be concerned about my readings?
  • Are lifestyle changes enough, or do I need medication adjustments?

The Bottom Line on TRT and Blood Pressure

The 2025 FDA blood pressure warnings don't invalidate TRT's safety profile—they refine our understanding of how to use testosterone therapy responsibly. Blood pressure increases are real, predictable, and manageable in the vast majority of men.

The key principles are straightforward:

  • Monitor blood pressure regularly, especially early in treatment
  • Implement lifestyle modifications proactively
  • Adjust antihypertensive medications as needed
  • Maintain communication between all healthcare providers
  • Remember that TRT's benefits typically outweigh manageable BP increases

For men with clinically diagnosed hypogonadism, properly monitored TRT remains a safe and effective treatment. The blood pressure warnings represent better medicine, not a reason to avoid treatment.

Blood pressure management on TRT is like managing any other aspect of men's health—it requires attention, but it doesn't require abandoning effective therapy.

Sources

  1. FDA Drug Safety Communication. "FDA issues class-wide labeling changes for testosterone products." February 2025. https://www.fda.gov/drugs/drug-safety-and-availability/fda-issues-class-wide-labeling-changes-testosterone-products
  1. Ambulatory Blood Pressure Monitoring Studies. "Cardiovascular Safety of Testosterone-Replacement Therapy: Insights from the TRAVERSE trial and beyond." European Expert Panel Position Statement. PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC12670475/
  1. Lincoff AM et al. "Cardiovascular Safety of Testosterone-Replacement Therapy." N Engl J Med. 2023;389(2):107-117. https://www.nejm.org/doi/full/10.1056/NEJMoa2215025
  1. Centers for Medicare & Medicaid Services. "Long Term Cardiovascular Safety of Testosterone Therapy: A Review of the TRAVERSE Study." PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11937349/
  1. American Heart Association. "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults." Hypertension. 2018;71(6):e13-e115.
  1. FDA SIDE EFFECTS UPDATE. "Testosterone Drugs and High Blood Pressure Risk." MedShadow Foundation. 2025. https://medshadow.org/drug-updates-recalls/fda-side-effect-updates/fda-side-effects-update-testosterone-drugs-and-high-blood-pressure-risk/

Frequently asked questions

Ready to get your testosterone checked?

At-home blood test, physician consultation, and treatment — starting at $99/month.

Get Started with PeterMD
Share —
MED — DISC

Medical Disclaimer. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any treatment. TRT requires a prescription from a licensed physician.

Read next